메뉴 건너뛰기




Volumn 25, Issue 2, 2011, Pages 193-197

Intravitreal bevacizumab for pediatric exudative retinal diseases

Author keywords

Bevacizumab; Coats' disease; Myopic CNVM; Pediatric; Retinal exudation

Indexed keywords

BEVACIZUMAB;

EID: 79954972028     PISSN: 13194534     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjopt.2011.01.012     Document Type: Article
Times cited : (7)

References (9)
  • 2
    • 33845745774 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
    • Issue
    • Haritoglou C., Kook D., Neubauer A., Wolf A., Priglinger S., Strauss R. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006, 26:999-1005. Issue.
    • (2006) Retina , vol.26 , pp. 999-1005
    • Haritoglou, C.1    Kook, D.2    Neubauer, A.3    Wolf, A.4    Priglinger, S.5    Strauss, R.6
  • 3
    • 55449105439 scopus 로고    scopus 로고
    • Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
    • Kusaka S., Shima C., Wada K., Arahori H., Shimojyo H., Sato T., Fujikado T. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br. J. Ophthalmol. 2008, 92(11):1450-1455.
    • (2008) Br. J. Ophthalmol. , vol.92 , Issue.11 , pp. 1450-1455
    • Kusaka, S.1    Shima, C.2    Wada, K.3    Arahori, H.4    Shimojyo, H.5    Sato, T.6    Fujikado, T.7
  • 5
    • 62549101271 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema
    • Özkirş A. Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema. Eye 2009, 23(3):616-620.
    • (2009) Eye , vol.23 , Issue.3 , pp. 616-620
    • Özkirş, A.1
  • 6
    • 0036480152 scopus 로고    scopus 로고
    • Review: coats disease: The 2001 LuEsther T. Mertz lecture
    • Shields J.A., Shields C.L. Review: coats disease: The 2001 LuEsther T. Mertz lecture. Retina 2002, 22:80-91.
    • (2002) Retina , vol.22 , pp. 80-91
    • Shields, J.A.1    Shields, C.L.2
  • 7
    • 34548022138 scopus 로고    scopus 로고
    • Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium
    • Sun Y., Jain A., Moshfeghi D.M. Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:1387-1388.
    • (2007) Graefes Arch. Clin. Exp. Ophthalmol. , vol.245 , pp. 1387-1388
    • Sun, Y.1    Jain, A.2    Moshfeghi, D.M.3
  • 9
    • 42049110754 scopus 로고    scopus 로고
    • Management of Coats disease with bevacizumab in 2 patients
    • Venkatesh P., Mandal S., Garg S. Management of Coats disease with bevacizumab in 2 patients. Can. J. Ophthalmol. 2008, 43:245-246.
    • (2008) Can. J. Ophthalmol. , vol.43 , pp. 245-246
    • Venkatesh, P.1    Mandal, S.2    Garg, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.